ALDOA and metastatic malignant neoplasm in the lymph nodes: In contrast, in the subgroup analysis distinguishing GC patients with lymph node metastasis from those without, the IHC score indicated a markedly higher expression of ALDOA in the lymph node metastasis group compared to the non-lymph node metastasis group (Fig. 1D).